Holden Pearmain Ramps Up Pharma Team

UK agency Holden Pearmain has expanded its Pharmaceutical and Healthcare Division with the appointment of senior directors Russell Mills and David White.

Mills, who joins with more than 15 years' pharma experience, most recently worked as a Director at European hospital specialist Next Research. Prior to this, he held senior roles at medeConnect Healthcare Insight, GfK Healthcare, A+A Healthcare Marketing Research, and Alexis Medical. Earlier in his career, Mills served as International Sales Manager at IMS (Medicare), where he was responsible for the launch of the firm's international data services.

Global marketing and product development specialist White joins after a 20 year career with TNS (now Kantar), where he held various director level positions at TNS WorldPanel and TNS Healthcare. Since leaving in 2008, he has worked as an independent consultant for agencies such as The Research Partnership, Dr Foster Intelligence and Nielsen. He began his career at BMRB.

The pair join Dan Coffin, who has worked for Holden Pearmain since 2008, having previously held senior roles at LifeScan, Roche UK, Hall & Partners, and Isis Research.

David Holden, MD of Holden Pearmain, comments: 'With these appointments we have added greater depth and experience across a whole range of therapy areas. Combining this with our expertise in sophisticated solutions, offered by Theano Anastasopoulou and Svetlana Gogolina from our Advanced Methods team, we can offer real value to our clients.'

Web site: www.holdenpearmain.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• All news